MedWatch

Demant plans to grow 23-27 percent after two awful years

Danish hearing aid firm Demant expects 23-27 percent organic growth during 2021, but highlights uncertainty regarding when life will be normalized after the Covid-19 crisis blew hole through hearing aid industry.

Photo: Jens Dresling/Politiken/Ritzau Scanpix

The world's second-largest hearing aid company, Denmark-domiciled Demant, has got the wheels back up and running following two awful years with a hacker attack and a Covid-19 beating.

Following a slow first half-year Demant has DKK 1.5bn (USD 243.7m) operating result to show for the second half-year of 2020, compared with the expected DKK1.38bn. The firm takes a positive outlook on the future.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs